| Drug |
Incidence |
| Abelcet Injection |
5% |
| Accolate Tablets |
1.9% |
| Aceon Tablets (2 mg, 4 mg, 8 mg) |
0.3% to 1% |
| Actiq |
1% or greater |
| Actonel Tablets |
7.7% to 13.6% |
| Adalat CC Tablets |
Less than 1% |
| Advair Diskus 100/50 |
1% to 3% |
| Advair Diskus 250/50 |
1% to 3% |
| Advair Diskus 500/50 |
1% to 3% |
| Advicor Tablets |
8% |
| Aggrenox Capsules |
6.4% |
| Agrylin Capsules |
15% |
| Aldara Cream, 5% |
1.4% |
| Alinia for Oral Suspension |
Less than 1% |
| Aloprim for Injection |
Less than 1% |
| Altoprev Extended-Release Tablets |
3% |
| AmBisome for Injection |
14% |
| Ambien Tablets |
Rare |
| Angiomax for Injection |
15% |
| Anzemet Injection |
2.4% |
| Aralast |
Greater than or equal to 0.2% |
| Arava Tablets |
2% |
| Aredia for Injection |
14.3% |
| Argatroban Injection |
4.6% |
| Aricept Tablets |
9% |
| Arimidex Tablets |
11% to 15% |
| Aromasin Tablets |
13% |
| Asacol Delayed-Release Tablets |
14% |
| AtacandHCT |
0.5% or greater |
| Atrovent Inhalation Solution |
4.1% |
| Avelox I.V. |
0.1% to less than 3% |
| Avelox Tablets |
0.1% to less than 3% |
| Avonex |
23% |
| Axid Oral Solution |
4.2% |
| Azmacort Inhalation Aerosol |
1% to 3% |
| Bactroban Ointment |
1.5% |
| Benicar Tablets |
Greater than 0.5% |
| Betaseron for SC Injection |
51% |
| Bextra Tablets |
0.1% to 1.9% |
| Bicillin L-A Injection |
|
| Bravelle for Intramuscular or Subcutaneous Injection |
3.5% to 5.7% |
| Busulfex I.V. |
2% to 44% |
| Caduet Tablets |
Greater than 0.1% to less than or equal to 1% |
| Campath Ampules |
2% to 24% |
| Campral Tablets |
2% to 4% |
| Camptosar Injection |
2.3% to 23.7% |
| Cancidas for Injection |
1.3% to 4.6% |
| Cardizem LA Extended-Release Tablets |
Less than 2% |
| Carnitor Injection |
21% to 35% |
| Casodex Tablets |
27% |
| Celebrex Capsules |
0.1% to 1.9% |
| CellCept Capsules, Intravenous, Oral Suspension, Tablets |
3% to 75.8% |
| Cenestin Tablets, 0.45 mg, 0.625 mg, 0.9 mg, 1.25 mg |
11% to 11.3% |
| Cialis Tablets |
Less than 2% |
| Cipro I.V. Pharmacy Bulk Package |
Less than 1% |
| Cipro I.V. |
1% or less |
| Cipro |
Less than 1% |
| Climara Pro Transdermal System |
5.2% |
| Climara Transdermal System |
1% to 11% |
| Colazal Capsules |
2% |
| CombiPatch Transdermal System |
15% to 19% |
| Combivent Inhalation Aerosol |
2.5% |
| Combivir Tablets |
12% |
| Copaxone for Injection |
28% |
| Copegus Tablets |
10% |
| Coumadin Tablets |
Infrequent |
| Coumadin for Injection |
Infrequent |
| Crestor Tablets |
Greater than or equal to 2% |
| Crinone 8% Gel |
8% |
| Cytovene |
At least 3 subjects |
| Denavir Cream |
|
| Depacon Injection |
1.3% |
| DepoCyt Injection |
3% to 11% |
| Desferal Vials |
|
| Ditropan XL Extended-Release Tablets |
6.8% |
| Doxil Injection |
3.4% to 7.2% |
| DuoNeb Inhalation Solution |
1.3% |
| DynaCirc CR Tablets |
0.5% to 1% |
| Effexor Tablets |
|
| Efudex |
Among most frequent |
| Eloxatin for Injection |
14% to 15% |
| Enbrel for Injection |
|
| Erbitux |
19% |
| EstroGel 0.06% |
7.1% |
| Evoxac Capsules |
3.3% |
| Exelon Capsules |
2% or more |
| Exelon Oral Solution |
2% or more |
| Fabrazyme for Intravenous Infusion |
6% |
| Factive Tablets |
Less than or equal to 0.1% |
| Famvir Tablets |
2% to 2.6% |
| Faslodex Injection |
18.9% |
| Femara Tablets |
5% |
| Ferrlecit Injection |
10% |
| Flonase Nasal Spray |
1% to 3% |
| Flovent HFA |
1% to 3% |
| Flovent Rotadisk |
1% to 3% |
| Flovent |
1% to 3% |
| Floxin Otic Singles |
Reported in a single subject |
| Floxin Otic Solution |
Single report |
| Floxin Tablets |
Less than 1% |
| Fludara for Injection |
20% to 22% |
| Fluorescite Injection |
|
| Forteo for Injection |
21.3% |
| Fortovase Capsules |
3.3% |
| Gabitril Tablets |
2% to 7% |
| Gemzar for Injection |
7% to 48% |
| Gengraf Capsules |
6% to 13% |
| Glucotrol XL Extended-Release Tablets |
Less than 30% |
| Gonal-F RFF Pen for Injection |
2.4% to 3% |
| HIVID Tablets |
Less than 1% |
| Hectorol Injection |
|
| Herceptin I.V. |
47% |
| Humatrope Vials and Cartridges |
6.25% to 13.6% |
| Hyalgan Solution |
|
| Hycamtin for Injection |
1.1% to 5.4% |
| Indapamide Tablets |
Greater than or equal to 5% |
| Infergen |
39% to 54% |
| Intron A for Injection |
Up to 18% |
| Invanz for Injection |
Greater than 0.1% |
| Jantoven Tablets |
Infrequent |
| K-Phos Neutral Tablets |
|
| K-Phos Original (Sodium Free) Tablets |
Less frequent |
| Kadian Capsules |
Less than 3% |
| Kaletra |
0.6% |
| Keppra Oral Solution |
7% |
| Keppra Tablets |
7% |
| Klonopin |
Infrequent |
| Lamictal |
More than 5% |
| Leukine |
17% |
| Levaquin in 5% Dextrose Injection |
1.4% |
| Levaquin |
1.4% |
| Levitra Tablets |
Less than 2% |
| Lofibra Capsules |
|
| Lotronex Tablets |
Rare |
| Lovenox Injection |
|
| Lupron Depot 3.75 mg |
12% |
| Lupron Depot 7.5 mg |
23.2% |
| Lupron Depot-3 month 11.25 mg |
12% |
| Lupron Depot-3 month 22.5 mg |
26.6% |
| Lupron Depot-4 month 30 mg |
4.2% to 32.7% |
| Lupron Depot-PED 7.5 mg, 11.25 mg and 15 mg |
2% |
| Lupron Injection Pediatric |
|
| Lupron Injection |
5% or more |
| Matulane Capsules |
|
| Menomune-A/C/Y/W-135 |
2% to 2.6% |
| Menostar Transdermal System |
13% |
| Mepron Suspension |
10% |
| Merrem I.V. |
Greater than 0.1% to 1% |
| Micardis HCT Tablets |
2% or greater |
| Micardis Tablets |
1% |
| Mirapex Tablets |
1% or more |
| Mobic Tablets |
0.9% to 3.6% |
| Monurol Sachet |
2.2% |
| Muse Urethral Suppository |
3% |
| Myfortic for Injection |
18% |
| Namenda Tablets |
3% |
| Naropin Injection |
1% to 5% |
| Neoral Oral Solution |
4.4% to 13% |
| Neoral Soft Gelatin Capsules |
4.4% to 13% |
| Neumega for Injection |
Greater than or equal to 10% |
| Neupogen for Injection |
2% |
| Neurontin Capsules |
More than 1% |
| Neurontin Oral Solution |
More than 1% |
| Neurontin Tablets |
More than 1% |
| Nexium Delayed-Release Capsules |
Less than 1% |
| Niaspan Extended-Release Tablets |
1% to 5% |
| Nilandron Tablets |
26.8% |
| Nipent for Injection |
8% to 20% |
| Norvasc Tablets |
More than 0.1% to 1% |
| Norvir |
1.7% to 2.2% |
| NovoSeven |
1% |
| Oncaspar |
Greater than 5% |
| Ontak Vials |
4.8% |
| Orthoclone OKT3 Sterile Solution |
Less than 1% |
| Orthovisc Injection |
2.5% |
| Oxistat Lotion |
0.4% |
| OxyContin Tablets |
Less than 1% |
| ParaGard T 380A Intrauterine Copper Contraceptive |
|
| Paxil CR Controlled-Release Tablets |
3% |
| Pediarix Vaccine |
0.3% to 30.5% |
| Pegasys |
11% |
| Periostat Tablets |
4% |
| Permax Tablets |
7% |
| Photofrin for Injection |
8% to 22% |
| Plavix Tablets |
6.4% |
| Plenaxis for Injectable Suspension |
Greater than or equal to 10% |
| Pletal Tablets |
Very rare |
| Pravachol Tablets |
1.4% to 10% |
| Premarin Tablets |
17% to 20% |
| Premarin Vaginal Cream |
|
| Premphase Tablets |
11% to 20% |
| Prempro Tablets |
11% to 20% |
| Prevacid Delayed-Release Capsules |
Less than 1% |
| Prevacid NapraPAC |
Less than 1% |
| Prevacid SoluTab Delayed-Release Orally Disintegrating Tablets |
Less than 1% |
| Prevacid for Delayed-Release Oral Suspension |
|
| Prevpac |
Less than 1% |
| Priftin Tablets |
1.9% |
| Prilosec OTC Tablets |
Less than 1% |
| Prinivil Tablets |
0.3% to 1% |
| Prinzide Tablets |
|
| ProAmatine Tablets |
4.9% |
| ProSom Tablets |
2% |
| Prochieve 4% Gel |
8% |
| Prochieve 8% Gel |
8% |
| Prograf Capsules and Injection |
24% to 63% |
| Proleukin for Injection |
12% |
| Protonix I.V. |
Greater than or equal to 1% |
| Protonix Tablets |
Greater than or equal to 1% |
| Protopic Ointment |
1% to 4% |
| Prozac Pulvules and Liquid |
|
| Qvar Inhalation Aerosol |
1% to 5% |
| Rapamune Oral Solution and Tablets |
24% to 33% |
| Raptiva for Injection |
10% |
| ReFacto Vials |
|
| Relpax Tablets |
Frequent |
| Renagel Tablets |
|
| ReoPro Vials |
3.4% to 5.4% |
| Requip Tablets |
8% |
| Rescriptor Tablets |
|
| Reyataz Capsules |
1% to 3% |
| Risperdal Consta Injection |
3% to 10% |
| Risperdal M-Tab Tablets |
5% |
| Risperdal |
5% |
| Rituxan I.V. |
0.3% |
| Rituxan for Infusion |
0.3% |
| Roferon-A Injection |
24% |
| Rythmol SR Capsules |
|
| Salagen Tablets |
4% |
| Serevent Diskus |
1% to 3% |
| Seroquel Tablets |
7% |
| Simulect for Injection |
Greater than or equal to 10% |
| Somavert Injection |
4% to 14% |
| Soriatane Capsules |
1% to 10% |
| Spectracef Tablets |
0.1% to 1% |
| Sporanox Capsules |
2% to 3% |
| Sporanox Injection |
1% |
| Sporanox Oral Solution |
1.8% to 2.3% |
| Suboxone Tablets |
22.4% to 24% |
| Subutex Tablets |
18.4% to 24% |
| Sulfamylon Topical Solution |
|
| Sustiva Capsules |
14% |
| Synagis |
8.5% |
| Synercid I.V. |
1.5% |
| Tasmar Tablets |
Infrequent |
| Taxotere Injection Concentrate |
7 of 134 patients |
| Teveten HCT Tablets |
Less than 1% |
| Teveten Tablets |
Less than 1% |
| Thalomid Capsules |
8.3% |
| Thymoglobulin for Injection |
46.3% |
| Thyrogen for Injection |
4 of 55 patients |
| Tiazac Capsules |
3% to 6% |
| Ticlid Tablets |
0.5% to 1% |
| Tikosyn Capsules |
Greater than 2% |
| Tobi Solution for Inhalation |
8.1% |
| Topamax Sprinkle Capsules |
More than 1% |
| Topamax Tablets |
More than 1% |
| Travatan Ophthalmic Solution |
1% to 5% |
| Trelstar Depot |
2.1% |
| Tricor Tablets |
|
| Trisenox Injection |
15% |
| Truvada Tablets |
|
| Uniretic Tablets |
More than 1% |
| Univasc Tablets |
Greater than 1% |
| Uroxatral Tablets |
1% to 2% |
| VFEND I.V. |
Less than 1% |
| VFEND Oral Suspension |
Less than 1% |
| VFEND Tablets |
Less than 1% |
| Vagifem Tablets |
3% to 5% |
| Valcyte Tablets |
Less than 5% |
| Vantin Tablets and Oral Suspension |
Less than 1% |
| Verelan PM Capsules |
2.4% |
| Vesanoid Capsules |
37% |
| Viadur Implant |
Less than 2% |
| Viagra Tablets |
Less than 2% |
| Vicoprofen Tablets |
Less than 3% |
| Videx EC Capsules |
|
| Vioxx |
Greater than 0.1% to 1.9% |
| Viracept |
Less than 2% |
| Viread Tablets |
7% to 12% |
| Vivelle Transdermal System |
|
| Vivelle-Dot Transdermal System |
|
| Voltaren Ophthalmic Solution |
Less than or equal to 3% |
| Voltaren Ophthalmic Sterile Ophthalmic Solution 0.1% |
Less than 3% |
| Welchol Tablets |
5% |
| Wellbutrin SR Sustained-Release Tablets |
2% to 3% |
| Wellbutrin Tablets |
Infrequent |
| Wellbutrin XL Extended-Release Tablets |
2% to 3% |
| Xeloda Tablets |
Less than 5% |
| Xifaxan Tablets |
Less than 2% |
| Xolair |
7% |
| Xopenex Inhalation Solution |
1.4% to 2.8% |
| Zegerid Powder for Oral Solution |
Less than 1% |
| Zemaira |
0.5% |
| Zenapax for Injection |
Greater than 5% |
| Zevalin Injection |
13% |
| Ziagen |
%3C1% |
| Zithromax Tablets, 250 mg, 500 mg |
1% or less |
| Zithromax Tri-Pak |
1% or less |
| Zithromax for Oral Suspension 300 mg, 600 mg, 900 mg, 1200 mg |
1% or less |
| Zoladex 3-month |
14% |
| Zoladex |
8% to 17% |
| Zoloft |
1% to 6% |
| Zomig Nasal Spray |
4% |
| Zomig Tablets |
2% to 3% |
| Zomig-ZMT Tablets |
2% to 3% |
| Zosyn |
1.7% to 3.2% |
| Zovirax Capsules |
|
| Zovirax Ointment |
|
| Zovirax for Injection |
|
| Zovirax |
|
| Zyban Sustained-Release Tablets |
Infrequent |
| Zyrtec Chewable Tablets |
Less than 2% |
| Zyrtec-D 12 Hour Extended-Release Tablets |
Less than 2% |
| Zyrtec |
Less than 2% |
| Zyvox |
|
This site complies with the HONcode standard for trustworthy health information: